CLDN5 and neoplasm: We treated brain endothelial cells with conditioned medium from brain metastatic cells and found that knockdown of MSLN inhibited the degradation of VE-cadherin, JAM-A and claudin-5 on brain endothelial cells, significantly reducing the number of tumor cells migrating across the endothelial layer.